UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How I treat refractory acute GVHD

Blood, 2007-05, Vol.109 (10), p.4119-4126

Deeg, H. Joachim

2007

Volltextzugriff (PDF)

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts

Annals of internal medicine, 2020-02, Vol.172 (4), p.229

2020

Volltextzugriff (PDF)

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

Journal of clinical oncology, 2017-04, Vol.35 (11), p.1154-1161

2017

Volltextzugriff (PDF)

Chimerism, the Microenvironment and Control of Leukemia

Frontiers in immunology, 2021-04, Vol.12, p.652105

Deeg, H Joachim

2021

Volltextzugriff (PDF)

Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53 -Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes

Journal of clinical oncology, 2022-12, Vol.40 (34), p.3985-3993

2022

Volltextzugriff (PDF)

SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

Cancer cell, 2015-05, Vol.27 (5), p.617-630

2015

Volltextzugriff (PDF)

Silver Lining: Reduced Relapse with Chronic GVHD after Transplant for MDS

Clinical cancer research, 2020-12, Vol.26 (24), p.6404-6405

2020

Volltextzugriff (PDF)

Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation

Journal of clinical oncology, 2010-02, Vol.28 (6), p.1011-1016

2010

Volltextzugriff (PDF)

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation

Journal of clinical oncology, 2014-10, Vol.32 (29), p.3249-3256

2014

Volltextzugriff (PDF)

Allogeneic Hematopoietic Cell Transplantation and Other Expensive Cellular Therapies: A Miracle for the Few but Off Limits to Many?

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1268-1272

2020

Volltextzugriff (PDF)

Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML

Blood, 2022-03, Vol.139 (11), p.1694-1706

2022

Volltextzugriff (PDF)

Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis

Journal of clinical oncology, 2013-07, Vol.31 (21), p.2662-2670

2013

Volltextzugriff (PDF)

Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell Transplantation

Journal of clinical oncology, 2007-09, Vol.25 (27), p.4246-4254

2007

Volltextzugriff (PDF)

Asymmetric dimethylarginine - a prognostic marker for transplant outcome?

Haematologica (Roma), 2019-04, Vol.104 (4), p.646-647

2019

Volltextzugriff (PDF)

Who is fit for allogeneic transplantation?

Blood, 2010-12, Vol.116 (23), p.4762-4770

2010

Volltextzugriff (PDF)

Elevated TWIST1 expression in myelodysplastic syndromes/acute myeloid leukemia reduces efficacy of hypomethylating therapy with decitabine

Haematologica (Roma), 2020-01, Vol.105 (10), p.e502

2020

Volltextzugriff (PDF)

Phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies

Journal of hematology and oncology, 2016-12, Vol.9 (1), p.137-12, Article 137

2016

Volltextzugriff (PDF)

Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia

Haematologica (Roma), 2017-07, Vol.102 (7), p.1291-1298

2017

Volltextzugriff (PDF)

Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis

Journal of clinical oncology, 2009-09, Vol.27 (27), p.4563-4569

2009

Volltextzugriff (PDF)

Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

Haematologica (Roma), 2023-01, Vol.108 (1), p.273-277

2023

Volltextzugriff (PDF)

Comparative analysis of total body irradiation (TBI)-based and non-TBI-based myeloablative conditioning for acute myeloid leukemia in remission with or without measurable residual disease

Leukemia, 2020-06, Vol.34 (6), p.1701-1705

2020

Volltextzugriff (PDF)

Reward from half a match

Blood, 2023-06, Vol.141 (25), p.3009-3010

Deeg, H. Joachim

2023

Volltextzugriff (PDF)

Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia

Haematologica (Roma), 2020-03, Vol.105 (3), p.652-660

2020

Volltextzugriff (PDF)

1 – 25 von 588

Suche als RSS-Feed

Aktive Filter

ThemaTransplantation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(515)
Mit Volltextzugriff
(474)

Publikationsform

Artikel
(570)
Buchkapitel
(15)
Bücher
(2)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(283)
Humans
(281)
Life Sciences & Biomedicine
(279)
Hematology
(183)
Biological And Medical Sciences
(159)
Medical Sciences
(146)
Female
(138)
Male
(136)
Adult
(123)
Middle Aged
(114)
Adolescent
(85)
Oncology
(78)
Aged
(77)
Animals
(76)
Bone Marrow Transplantation
(75)
Child
(71)
Treatment Outcome
(67)
Transplantation, Homologous
(66)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(58)
Hematologic And Hematopoietic Diseases
(58)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

How I treat refractory acute GVHD

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

Chimerism, the Microenvironment and Control of Leukemia

Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53 -Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes

SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

Silver Lining: Reduced Relapse with Chronic GVHD after Transplant for MDS

Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation

Allogeneic Hematopoietic Cell Transplantation and Other Expensive Cellular Therapies: A Miracle for the Few but Off Limits to Many?

Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML

Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis

Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell Transplantation

Asymmetric dimethylarginine - a prognostic marker for transplant outcome?

Who is fit for allogeneic transplantation?

Elevated TWIST1 expression in myelodysplastic syndromes/acute myeloid leukemia reduces efficacy of hypomethylating therapy with decitabine

Phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies

Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia

Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation

Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis

Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

Comparative analysis of total body irradiation (TBI)-based and non-TBI-based myeloablative conditioning for acute myeloid leukemia in remission with or without measurable residual disease

Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation

Reward from half a match

Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia

Aktive Filter

Suchergebnisse filtern